Free shipping on all orders over $ 500

VER-49009

Cat. No. M3117

All AbMole products are for research use only, cannot be used for human consumption.

VER-49009 Structure
Synonym:

CCT0129397

Size Price Availability Quantity
1mg USD 75 In stock
5mg USD 225 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

VER-49009 is a potent HSP90 inhibitor with IC50 of 47 nM for HSP90β.

Protocol (for reference only)
Cell Experiment
Cell lines Melanoma cells (SKMEL 2, SKMEL 5, SKMEL 28, WM266.4); Colon cancer cells (HCT116, BEneg, BE2, HT29, HT29oxaliR); Ovarian cancer cells (CH1, CH1doxR); Breast cancer cells (MB-231, MB-468, BT20, ZR751, MCF7, BT-474); nontumorigenic cells (HUVEC, MCF10a, PNT
Preparation method Using the sulforhodamine B assay to mearsure antiproliferative effects . Determining HUVEC sensitivity by an alkaline phosphatase method.
Concentrations ~10 μM
Incubation time 4 days
Animal Experiment
Animal models Mice bearing established OVCAR3 human ovarian xenografts
Formulation 10% DMSO, 5% Tween 20, 85% saline
Dosages ~4 mg/kg
Administration i.p.
Chemical Information
Molecular Weight 387.82
Formula C19H18ClN3O4
CAS Number 940289-57-6
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Chul-Ho Jeong, et al. Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC)

[2] Xu Sun, et al. Inhibition of hepatic stellate cell proliferation by heat shock protein 90 inhibitors in vitro

[3] Nathalie Gaspar, et al. Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells

[4] Swee Y Sharp, et al. Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues

[5] Xavier Barril, et al. 4-Amino derivatives of the Hsp90 inhibitor CCT018159

Related HSP Products
BIIB021

BIIB021 (CNF2024) is an orally available synthetic non-ansamycin Hsp90 inhibitor with ki value of 1.7nM.

CUDC-305

CUDC-305 is a heat shock protein 90 (HSP90) inhibitor of the novel imidazopyridine class, with IC50 values of 100 and 103 nM for HSP90α and HSP90β, respectively.

Ganetespib

Ganetespib (STA-9090) is a potent synthetic small molecule inhibitor of Hsp90 with potential antineoplastic activity.

Luminespib (AUY922)

Luminespib (AUY922) is a small molecule Heat Shock Protein 90 (HSP90) inhibitor with IC50 values of 13 and 21 nM for HSP90α and HSP90β respectively.

NVP-HSP990

NVP-HSP990 is an orally bioavailable inhibitor of human heat-shock protein 90 (Hsp90) with IC50 values of 0.6, 0.8, and 8.5 nM for Hsp90α, Hsp90β, and Grp94, respectively. NVP-HSP990 has potential antineoplastic activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: VER-49009, CCT0129397 supplier, HSP, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.